Skip to main content

Day: September 2, 2025

Fusion Fuel’s BrightHy Solutions Wins Tender Processes to Advance to Final Contract Negotiations for Two Green Hydrogen Projects in Southern Europe

Dublin, Ireland, Sept. 02, 2025 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), today announced that its subsidiary, Bright Hydrogen Solutions Ltd (“BrightHy Solutions”), has been selected to advance to final contract negotiations as part of two tender processes to develop two new green hydrogen projects in southern Europe. BrightHy Solutions was selected as the preferred partner to advance to the negotiations of the final contract for the development of a 2 MW hydrogen project for a cement company in southern Europe, aimed at supplying both hydrogen and oxygen as part of the client’s decarbonization objectives. This project would be the first project in the Company’s proposed hydrogen investment partnership structure, in which the Company would receive a €30 million commitment under terms...

Continue reading

Safe Harbor Financial Launches Industry’s First Fully Managed Cannabis Banking Program for Financial Institutions

Turnkey platform offers banks and credit unions cannabis deposits with lower overhead and workload, reduced regulatory and operational risks and no reputational exposure DENVER, Sept. 02, 2025 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a Safe Harbor Financial (Safe Harbor or the “Company”) (Nasdaq: SHFS), a fintech leader in providing financial services and credit facilities to the regulated cannabis industry, announced the official launch of its Fully Managed Cannabis Banking Program, the industry’s first and only solution offering complete operational and compliance outsourcing for financial institutions. The announcement comes ahead of CEO Terry Mendez’s participation in the PBC Conference 2025, where he will join industry leaders to discuss the future of cannabis banking, reinforcing the Company’s commitment to delivering compliant,...

Continue reading

Apollo to Proceed with 5-for-1 Share Consolidation

VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) —  Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce that, further to the Company’s news release dated October 3, 2024, it intends to proceed with the consolidation (the “Consolidation”) of its issued and outstanding common shares (“Shares”) on the basis of five (5) pre-Consolidation Shares for every one (1) post-Consolidation Share. “Consolidation of the Company Shares should result in a price environment that allows for immediate marginability, the opportunity of greater blue-sky potential in the US and foreign markets, increased sophisticated investor interest and greater opportunity for inclusion in various indexes and/or index funds. In addition, few of the Company’s peer groups are margin eligible, providing...

Continue reading

eMaint Named a Leader in the Verdantix Green Quadrant for CMMS – One of Only Two Vendors Also Recognized for EAM

Dual recognition showcases eMaint’s depth across both maintenance execution and enterprise asset strategyeMaint Named a Leader in the Verdantix Green Quadrant for CMMS – One of Only Two Vendors Also Recognized for EAMeMaint Named a Leader in the Verdantix Green Quadrant for CMMSNorwich, UK, Sept. 02, 2025 (GLOBE NEWSWIRE) — Tuesday 2nd September, Norwich, UK – eMaint, which empowers reliability and maintenance teams with the Enterprise Asset Management software needed to optimize asset performance, today announced that it has been positioned as a Leader in the 2025 Verdantix Green Quadrant for Computerized Maintenance Management Systems (CMMS). This recognition follows eMaint’s Leader placement in the 2025 Verdantix Green Quadrant for Enterprise Asset Management (EAM), making it one of only two companies to be named...

Continue reading

Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy

Selective APRIL inhibition has shown disease-modifying potential in IgAN patient clinical trials JADE101 has shown ultra-high binding affinity and a differentiated pharmacokinetic and pharmacodynamic profile preclinically, supporting the potential for patient-friendly subcutaneous dosing every eight weeks or longer Interim, biomarker-rich Phase 1 healthy volunteer data are expected in the first half of 2026, and are anticipated to define dose and dosing interval selection based on biomarker responses associated with optimal clinical activity in IgAN patientsSAN FRANCISCO and VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) — Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced...

Continue reading

Fury Announces Results of Preliminary Economic Assessment for the Eau Claire Gold Deposit with a Base Case After-Tax NPV (5%) of $554M and After-Tax IRR of 41%

Figure 11Eau Claire Resource Long Section Looking North. The inset depicts the improved geometry of modelled veins within the eastern portion of the resource.TORONTO, Sept. 02, 2025 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company”) is pleased to announce results from a preliminary economic assessment (PEA) for the high-grade Eau Claire deposit located in the Eeyou Istchee Territory of the James Bay region of Quebec. The PEA represents an initial conceptual evaluation of the economic potential of Eau Claire’s mineral resources and was prepared in accordance with National Instrument 43-101 (“NI 43-101”) by SGS Geological Services. All dollar amounts are in Canadian dollars unless otherwise specified. Three scenarios, all based on the same mine plan, were evaluated, each returning...

Continue reading

Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate

EDIT-401 achieved ~90% mean LDL-C reduction with single dose in non-human primates EDIT-401 on track for human proof-of-concept data by end of 2026 Strong cash position with operational runway into second quarter of 2027 Company-sponsored webinar on EDIT-401 today at 8:00 a.m. ET CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced the nomination of its lead in vivo development candidate, EDIT-401, an experimental, potential best-in-class, one-time therapy designed to significantly reduce LDL cholesterol (LDL-C) levels. “Today’s nomination of EDIT-401 as our lead in vivo development candidate is a significant milestone in our long-term vision to lead the field of in vivo programmable gene editing,” said Gilmore O’Neill, M.B., M.M.Sc., President...

Continue reading

Baker Hughes Selected by Fervo Energy to Deliver Geothermal Power Generation Equipment for Innovative New Power Plants

Baker Hughes to design and deliver key equipment for geothermal Organic Rankine Cycle (ORC) power plants at Fervo’s Cape Station Phase II project in Utah Award includes Baker Hughes turboexpander, BRUSH™ Power Generation generator and other related equipmentHOUSTON and LONDON, Sept. 02, 2025 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR), an energy technology company, announced Tuesday an award from Fervo Energy Company, the leader in next-generation geothermal energy, to design and deliver equipment for five Organic Rankine Cycle (ORC) power plants at Fervo’s Cape Station power generation project near Milford, Utah, United States. Once operational, the five Cape Phase II ORC plants will generate approximately 300 megawatts of clean, reliable, and affordable power to the grid, equivalent power to approximately 180,000...

Continue reading

Playboy to Participate in Lake Street’s Best Ideas Growth Conference

LOS ANGELES, Sept. 02, 2025 (GLOBE NEWSWIRE) — Playboy, Inc. (Nasdaq: PLBY) (the “Company” or “Playboy”), one of the most recognizable and iconic brands in the world, announced today that management will participate in the 9th Annual Lake Street Capital Markets Best Ideas Growth (BIG9) Conference taking place in New York City on September 11, 2025. Ben Kohn, CEO, will be available for one-on-one meetings with attending investors throughout the day. To schedule a one-on-one meeting with management, investors are encouraged to contact their Lake Street representative or reach out to Playboy’s investor relations team at plby@fnkir.com. About Playboy, Inc. Playboy, Inc. is a global pleasure and leisure company connecting consumers with products, content, and experiences that help them lead happier, more fulfilling lives. Playboy is...

Continue reading

Gaming & Leisure Properties Furthers Tribal Partnership With Accretive Long-Term Financing for Caesars Republic Sonoma County

$225 MM FINANCING COMMITMENT AT A BLENDED RATE OF 12.79% A 45-YEAR TERM LEASE OF AT LEAST $112.5 MM AT A 9.75% CAP RATEWYOMISSING, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (“GLPI”) today announced its $225 million commitment to serve as the lead real estate financing partner for a new, integrated resort, Caesars Republic Sonoma County, that will be developed on the site of the current River Rock Casino. Pursuant to its agreements with Caesars Entertainment (NASDAQ: CZR) (“Caesars”) and the Dry Creek Rancheria Band of Pomo Indians (“Dry Creek”), GLPI will initially act as a lender to the project, with a delayed draw term loan of $180 million, priced at a fixed rate of 12.50%, and a term loan B of $45 million, with a current yield to maturity of 13.95%. The blended interest rate...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.